Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by JKS Communications naming Stephen Donnelly .
Filed returns
10
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2023 | JKS Communications | Health | MediQRLink (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2023 | JKS Communications | Development and Zoning | Old Conna LAP, development at Fassaroe (Zoning or development) | 4 | On lobbying.ie |
| May–Aug 2022 | JKS Communications | Health | AV Room Meeting in Leinster House for Neurological Alliance of Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | JKS Communications | Health | Reimbursement for Luxturna gene theraphy for rare retinal disease (Matters involving public funds) | 7 | On lobbying.ie |
| Sep–Dec 2020 | JKS Communications | Development and Zoning | Briefing on Fassaroe Development in Bray (Zoning or development) | 4 | On lobbying.ie |
| Sep–Dec 2020 | JKS Communications | Health | Statutory funding for LauraLynn - Programme for Government Commitments/pre Budget Submission (Matters involving public funds) | 4 | On lobbying.ie |
| May–Aug 2020 | JKS Communications | Health | Statutory funding for LauraLynn - Programme for Government Commitments (Matters involving public funds) | 9 | On lobbying.ie |
| May–Aug 2020 | JKS Communications | Development and Zoning | Briefing on Fassaroe Development in Bray (Zoning or development) | 3 | On lobbying.ie |
| Jan–Apr 2020 | JKS Communications | Development and Zoning | Development at Fassaroe Co Wicklow (Zoning or development) | 2 | On lobbying.ie |
| Sep–Dec 2018 | JKS Communications | Health | Costs of and access to oncology drugs (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 6 | 60.0% | |
| Development and Zoning | 4 | 40.0% |